Haemostatic defects in cyanotic congenital heart disease.

An investigation of defects of the haemostatic mechanism in 41 children with cyanotic congenital heart disease concluded that such abnormalities were common and normally involved factors synthesised in the liver, that is the vitamin K dependent factors (rothrombin, factors VII and IX) and factor V. No evidence was found of activation of the coagulation or fibrinolytic systems. The defects can be explained by deficient synthesis resulting from systemic hypoxia as well as from sluggishness of the local microcirculation caused by high blood viscosity. Vitamin K parenterally had no demonstrable effect. Replacement of these factors, possibly combined with measures to improve the microcirculation, therefore, appears to be the appropriate treatment.

[1]  P. Henriksson,et al.  Factor XIII in a clinical material. , 2009, Scandinavian journal of haematology.

[2]  B. Sarkadi,et al.  Platelet producton and survival in cyanotic congenital heart disease. , 2009, Scandinavian journal of haematology.

[3]  I. Nilsson,et al.  Immunologic studies in haemophilia A. , 2009, Scandinavian journal of haematology.

[4]  A. F. Abrahamsen.  A modification of the technique for 51Cr-labelling of blood platelets giving increased circulating platelet radioactivity. , 2009, Scandinavian journal of haematology.

[5]  I. Nilsson,et al.  Haemophilia in Sweden. I. Coagulation studies. , 2009, Acta medica Scandinavica.

[6]  M. Blombäck,et al.  On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. , 2009, Acta medica Scandinavica.

[7]  P. Henriksson,et al.  FACTOR VIII ACTIVITY AND ANTIGEN IN SICK NEWBORNS WITH PATHOLOGICAL PROTEOLYSIS IN BLOOD , 1978, Acta paediatrica Scandinavica.

[8]  M. Hayet.  [Prolonged bleeding time]. , 1977, Soins; la revue de reference infirmiere.

[9]  N. Ohshima,et al.  Hemorheology in hyper- and hypoviscosity syndrome. , 1976, Thrombosis research.

[10]  I. Nilsson,et al.  Various Prothrombin Complex Concentrates and their Effect on Coagulation and Fibrinolysis In Vivo , 1976, Thrombosis and Haemostasis.

[11]  M. Paul,et al.  Shortened platelet survival in cyanotic heart disease. , 1975, The Journal of pediatrics.

[12]  R. Turner,et al.  Fibrinolysis in cyanotic and acyanotic children before and after open intracardiac operations with the Bently Temptrol oxygenator. , 1975, The Journal of thoracic and cardiovascular surgery.

[13]  B. Møller,et al.  Letter: Acute oliguric glomerulonephritis. , 1975, Lancet.

[14]  J. Stuart,et al.  Excess intravascular coagulation complicating low cardiac output. , 1975, Journal of clinical pathology.

[15]  S. Kaplan,et al.  Cerebral vascular accidents in cyanotic congenital heart disease. , 1973, American journal of diseases of children.

[16]  J. Emery,et al.  Hypoxia and asymmetrical fibrosis of the liver in children , 1973, Gut.

[17]  J. Stuart,et al.  Consumption coagulopathy in congenital heart-disease. , 1973, Lancet.

[18]  K. Terplán.  Patterns of brain damage in infants and children with congental heart disease. Association with catheterization and surgical procedures. , 1973, American journal of diseases of children.

[19]  A. Wedemeyer,et al.  Coagulation in cyanotic congenital heart disease. , 1972, American journal of diseases of children.

[20]  H. Maurer.  Hematologic effects of cardiac disease. , 1972, Pediatric clinics of North America.

[21]  I. Nilsson,et al.  Technical Remarks on the Microscopical Demonstration of Tissue Plasminogen Activator , 1972, Thrombosis and Haemostasis.

[22]  I. Nilsson,et al.  Quantitative determination of platelet fibrinogen. , 1971, The Journal of laboratory and clinical medicine.

[23]  U. Abildgaard,et al.  Assay of Progressive Antithrombin in Plasma , 1970, Thrombosis and Haemostasis.

[24]  D. Cottom,et al.  Effect of Asphyxia on Thrombotest Values in Low Birthweight Infants , 1970, Archives of disease in childhood.

[25]  N. J. Iolster.  Blood coagulation in children with cyanotic congenital heart disease. , 1970, Acta paediatrica Scandinavica.

[26]  H. Gralnick.  ∈-AMINOCAPROIC ACID IN PREOPERATIVE CORRECTION OF HÆMOSTATIC DEFECT IN CYANOTIC CONGENITAL HEART-DISEASE , 1970 .

[27]  I. Nilsson,et al.  Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. , 1970, Scandinavian journal of clinical and laboratory investigation.

[28]  S. Kontras,et al.  Hyperviscosity in congenital heart disease. , 1970, The Journal of pediatrics.

[29]  D. Hammond,et al.  Hemostasis in cyanotic congenital heart disease. , 1970, The Journal of pediatrics.

[30]  D. Komp,et al.  Polycythemia in cyanotic heart disease--a study of altered coagulation. , 1970, The Journal of pediatrics.

[31]  Mckay Dg.  Progress in disseminated intravascular coagulation. II. , 1969 .

[32]  P. O. Ganrot,et al.  Immunochemical determination of human plasminogen. , 1968, Clinica chimica acta; international journal of clinical chemistry.

[33]  J. Liebman,et al.  The platelets in cyanotic congenital heart disease. , 1968, Pediatrics.

[34]  C. Johnson,et al.  Absence of coagulation abnormalities in children with cyanotic congenital heart-disease. , 1968, Lancet.

[35]  Niléhn Je.  Separation and estimation split "products" of fibrinogen and fibrin in human serum. , 1967 .

[36]  M. Markarian,et al.  Coagulation Factors in Pregnant Women and Premature Infants with and without the Respiratory Distress Syndrome , 1967, Thrombosis and Haemostasis.

[37]  M. Conrad,et al.  Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease. , 1967, Lancet.

[38]  S. Kontras,et al.  Hematologic abnormalities in children with congenital heart disease. , 1966, JAMA.

[39]  P. Ms,et al.  HYPOPITUITARISM AFTER CHILDBIRTH. , 1965 .

[40]  U. Bucher,et al.  [THROMBOCYTOPENIA IN CHRONIC COR PULMONALE AND CYANOTIC HEART DEFECTS]. , 1964, Schweizerische medizinische Wochenschrift.

[41]  I. Nilsson,et al.  Determination of Fibrinogen and Fibrinogenolytic Activity , 1962, Thrombosis and Haemostasis.

[42]  W. Krivit,et al.  Problems in hemostasis during and after open-heart surgery. VI. Over-all changes in blood coagulation mechanism. , 1962, JAMA.

[43]  E. Merrill,et al.  Measurement of viscosity of biologic fluids by cone plate viscometer. , 1961, The Journal of laboratory and clinical medicine.

[44]  C. Ferencz.  The pulmonary vascular bed in tetralogy of Fallot. I. Changes associated with pulmonic stenosis. , 1960, Bulletin of the Johns Hopkins Hospital.

[45]  Hartmann Rc.  A hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. , 1952 .

[46]  D. Sabiston,et al.  Cerebral lesions in congenital heart disease, a review of autopsies on 162 cases. , 1951, Bulletin of the Johns Hopkins Hospital.

[47]  W. Paton.  The molecular basis of drug toxicity , 1975 .

[48]  I. Nilsson,et al.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. , 1972, Acta chirurgica Scandinavica.

[49]  B. Goldschmidt.  Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease. , 1970, Acta paediatrica Academiae Scientiarum Hungaricae.

[50]  I. Brodsky,et al.  Fibrinolysis in Congenital Heart Disease: Preoperative Treatment with ϵ-Aminocaproic Acid , 1969 .

[51]  J. Niléhn.  Separation and Estimation of Split “Products” of Fibrinogen and Fibrin in Human Serum , 1967, Thrombosis and Haemostasis.

[52]  A. Mcfarlane,et al.  Labelling of plasma proteins with radioactive iodine. , 1956, The Biochemical journal.

[53]  R. Hartmann.  A hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. , 1952, Bulletin of the Johns Hopkins Hospital.

[54]  M. Berthrong,et al.  Cerebral lesions in congenital heart disease. , 1951, Journal of neuropathology and experimental neurology.

[55]  H. Bahnson,et al.  A consideration of the causes of death following operation for congenital heart disease of the cyanotic type. , 1950, Surgery, gynecology & obstetrics.

[56]  Ziegler Rf,et al.  A consideration of the causes of death following operation for congenital heart disease of the cyanotic type. , 1950 .